skip navigation Smaller text size Reset text size Larger text size
Families & Children Women Teens Adults Seniors People with Disabilities
September is National Newborn Screening Awareness Month

The Newborn Screening program ensures all infants born in New Hampshire are screened at birth for inherited medical disorders. Screening shortly after birth for these serious conditions allows doctors to start appropriate treatment early, if needed. As a new or expecting parent you may find the following resources helpful.


BabyThe Newborn Screening Program is responsible for assuring that all infants born in New Hampshire are screened at birth for inherited medical disorders. A few drops of blood are taken from an infant's heel 24-72 hours after birth. This is in accordance with state legislation (RSA 132:10a). The goal of this screening is early identification of these conditions so that timely treatment and intervention can take place. Untreated, some of these conditions can cause death and disability. Families may refuse this screening if they wish.

The Newborn Screening Program is responsible for handling screening results and follow-up of out-of-range results, as needed. Parents are encouraged to ask their health care provider about the newborn screening results at their baby's two-week office visit.

Critical Congenital Heart Defects (CCHD)

Babies born with a Critical Congenital Heart Defect (CCHD) are at significant risk for disability or death if not diagnosed soon after birth. Although screening for CCHD is not officially part of the NH Newborn Screening Panel, as of August 11, 2011, CCHD screening by birth hospitals, midwives and birth attendants is now required by law in New Hampshire. For more information about screening for CCHD and to print a fact sheet, check the Centers for Disease Control and Prevention (CDC) website Adobe Acrobat Reader Symbol

Fact Sheets

Health Care Providers

Parents – English

Parents – Spanish

New Hampshire has a Newborn Screening Advisory Committee that makes recommendations to the state program on clinical, educational or operational aspects of the program. This committee meets at least annually.

The screening panel includes screening for the following conditions:

  • 3-Hydroxy-3-Methylglutaryl-CoA Lysase Deficiency
  • 3-Methylcrotonyl-CoA Carboxylase Deficiency
  • Argininosuccinic Aciduria
  • Argininemia
  • Biotinidase
  • Carnitine Uptake Defect
  • Carnitine Palmitoyltransferase II Deficiency
  • Citrullinemia I (ASA Synthetase Def)
  • Cobalamin A, B
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Toxoplasmosis
  • Cystic Fibrosis (CF)
  • Galactosemia
  • Glutaric Aciduria Type I
  • Homocystinuria (HCY)
  • Hyperornithinemia
  • Hyperammoninemia
  • Homocitrullinemia Syndrome
  • Isovaleric Acidemia
  • Long Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
  • Maple Syrup Urine Disease (MSUD)
  • Medium Chain Acyl CoA Dehydrogenase Deficiency (MCAD)
  • Methylmalonic Acidemia
  • Mitochondrial Acetoacetyl-CoA Thiolase Deficiency
  • Multiple Acyl-CoA Dehydrogenase Deficiency
  • Multiple Carboxylase Deficiency
  • Phenylketonuria (PKU)
  • Propionic Acidemia
  • Sickle Cell Disease (Hemoglobinopathies – 3 types)
  • Trifunctional Protein Deficiency
  • Tyrosinemia type I
  • Very Long Chain Acyl-CoA Dehydrogenase Deficiency

Adobe Acrobat Reader Symbol Adobe Acrobat Reader format. You can download a free reader from Adobe.

Translate this page


New Hampshire Department of Health and Human Services
129 Pleasant Street | Concord, NH | 03301-3852

copyright 2016. State of New Hampshire